Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRSR2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,653
Award facts
- Contract value 100% obligated
- $14,652.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,652.60 by the Defense Logistics Agency on August 14, 2025, for the supply of Stelara 45 mg/0.5 mL syringes. The contract utilizes firm fixed price pricing with an ultimate completion date of August 15, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
The delivery order supports the Defense Logistics Agency's Medical Supply Chain operations and is part of AmerisourceBergen's extensive portfolio of federal medical product deliveries to the Department of Defense and related healthcare systems. AmerisourceBergen's demonstrated capability to fulfill competitive federal procurement requirements across diverse therapeutic domains—including specialty medications, vaccines, and medical devices—positions the company as a critical vendor for military and veteran healthcare needs. The product being delivered, Stelara, is a biologic immunosuppressant commonly used to treat inflammatory conditions, reflecting the company's role in providing specialized pharmaceutical commodities to support defense health requirements.
Quick answers
Who was awarded contract SPE2DB25FRSR2?
SPE2DB25FRSR2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FRSR2 worth?
The government has obligated $14,653 on SPE2DB25FRSR2.
Is contract SPE2DB25FRSR2 an order under another contract?
Yes. SPE2DB25FRSR2 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRSR2 competed?
The extent of competition for SPE2DB25FRSR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award